| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopolyphosphatase activity | 3.41e-11 | 5 | 163 | 5 | GO:0000298 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-hexaphosphatase activity | 3.41e-11 | 5 | 163 | 5 | GO:0034431 | |
| GeneOntologyMolecularFunction | diphosphoinositol-polyphosphate diphosphatase activity | 3.41e-11 | 5 | 163 | 5 | GO:0008486 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-pentaphosphatase activity | 2.03e-10 | 6 | 163 | 5 | GO:0034432 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | TDRD9 KIF26A COQ8B RNF213 MCM6 ATP10B NUDT4B MFN1 GTPBP2 NUDT11 NUDT4 NUDT3 RECQL5 NUDT10 NAV3 GNB4 ATP11A DNAH6 RHOT1 DNAH11 | 1.73e-05 | 839 | 163 | 20 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | TDRD9 KIF26A COQ8B RNF213 MCM6 ATP10B NUDT4B MFN1 GTPBP2 NUDT11 NUDT4 NUDT3 RECQL5 NUDT10 NAV3 GNB4 ATP11A DNAH6 RHOT1 DNAH11 | 1.76e-05 | 840 | 163 | 20 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | TDRD9 KIF26A COQ8B RNF213 MCM6 ATP10B NUDT4B MFN1 GTPBP2 NUDT11 NUDT4 NUDT3 RECQL5 NUDT10 NAV3 GNB4 ATP11A DNAH6 RHOT1 DNAH11 | 1.76e-05 | 840 | 163 | 20 | GO:0016818 |
| GeneOntologyMolecularFunction | inositol bisdiphosphate tetrakisphosphate diphosphatase activity | 6.62e-05 | 2 | 163 | 2 | GO:0052841 | |
| GeneOntologyMolecularFunction | inositol diphosphate pentakisphosphate diphosphatase activity | 6.62e-05 | 2 | 163 | 2 | GO:0052842 | |
| GeneOntologyMolecularFunction | inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity | 6.62e-05 | 2 | 163 | 2 | GO:0052848 | |
| GeneOntologyMolecularFunction | inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity | 6.62e-05 | 2 | 163 | 2 | GO:0052845 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | TRAF3IP2 RNF213 ZSWIM2 MIB2 BIRC7 RNF157 TRIM33 RNF5 UBR5 TRIM56 MGRN1 | 2.49e-04 | 372 | 163 | 11 | GO:0061630 |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | TRAF3IP2 ATG16L1 RNF213 ZSWIM2 MIB2 BIRC7 FBXL21P RNF157 TRIM33 RNF5 UBR5 TRIM56 MGRN1 | 3.04e-04 | 512 | 163 | 13 | GO:0019787 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.93e-04 | 4 | 163 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | TRAF3IP2 ATG16L1 RNF213 ZSWIM2 MIB2 BIRC7 FBXL21P RNF157 TRIM33 RNF5 UBR5 TRIM56 MGRN1 | 4.37e-04 | 532 | 163 | 13 | GO:0016755 |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | TRAF3IP2 RNF213 ZSWIM2 MIB2 BIRC7 RNF157 TRIM33 RNF5 UBR5 TRIM56 MGRN1 | 4.40e-04 | 398 | 163 | 11 | GO:0061659 |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | TRAF3IP2 RNF213 ZSWIM2 MIB2 BIRC7 FBXL21P RNF157 TRIM33 RNF5 UBR5 TRIM56 MGRN1 | 5.23e-04 | 473 | 163 | 12 | GO:0004842 |
| GeneOntologyMolecularFunction | ATP-dependent activity | EP400 TDRD9 KIF26A TMEM94 COQ8B RNF213 MCM6 ATP10B MSH6 RECQL5 NAV3 ATP11A DNAH6 DNAH11 | 5.25e-04 | 614 | 163 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 9.72e-04 | 6 | 163 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | TDRD9 KIF26A COQ8B RNF213 MCM6 ATP10B RECQL5 NAV3 ATP11A DNAH6 DNAH11 | 1.02e-03 | 441 | 163 | 11 | GO:0016887 |
| GeneOntologyMolecularFunction | deubiquitinase activator activity | 1.35e-03 | 7 | 163 | 2 | GO:0035800 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | TDRD9 KIF26A COQ8B RNF213 MCM6 ATP10B MFN1 GTPBP2 RECQL5 NAV3 GNB4 ATP11A DNAH6 RHOT1 DNAH11 | 1.74e-03 | 775 | 163 | 15 | GO:0017111 |
| GeneOntologyBiologicalProcess | adenosine 5'-(hexahydrogen pentaphosphate) metabolic process | 2.90e-11 | 5 | 163 | 5 | GO:1901910 | |
| GeneOntologyBiologicalProcess | adenosine 5'-(hexahydrogen pentaphosphate) catabolic process | 2.90e-11 | 5 | 163 | 5 | GO:1901911 | |
| GeneOntologyBiologicalProcess | diadenosine pentaphosphate catabolic process | 2.90e-11 | 5 | 163 | 5 | GO:1901907 | |
| GeneOntologyBiologicalProcess | diadenosine pentaphosphate metabolic process | 2.90e-11 | 5 | 163 | 5 | GO:1901906 | |
| GeneOntologyBiologicalProcess | diadenosine hexaphosphate catabolic process | 2.90e-11 | 5 | 163 | 5 | GO:1901909 | |
| GeneOntologyBiologicalProcess | diadenosine hexaphosphate metabolic process | 2.90e-11 | 5 | 163 | 5 | GO:1901908 | |
| GeneOntologyBiologicalProcess | diphosphoinositol polyphosphate metabolic process | 2.90e-11 | 5 | 163 | 5 | GO:0071543 | |
| GeneOntologyBiologicalProcess | diadenosine polyphosphate catabolic process | 1.73e-10 | 6 | 163 | 5 | GO:0015961 | |
| GeneOntologyBiologicalProcess | diadenosine polyphosphate metabolic process | 3.56e-09 | 9 | 163 | 5 | GO:0015959 | |
| GeneOntologyBiologicalProcess | inositol phosphate metabolic process | 3.35e-06 | 52 | 163 | 6 | GO:0043647 | |
| GeneOntologyBiologicalProcess | polyol metabolic process | 6.11e-06 | 123 | 163 | 8 | GO:0019751 | |
| GeneOntologyBiologicalProcess | autophagosome organization | 8.68e-06 | 129 | 163 | 8 | GO:1905037 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRAF3IP2 USP34 ATG16L1 SLF1 RNF213 ZSWIM2 MIB2 BIRC7 KBTBD2 FBXL21P RNF157 CCNF FEM1B TRIM33 RNF5 UBR5 TRIM56 N4BP1 KLHL12 FBXL2 USP3 KLHL18 MGRN1 | 1.29e-05 | 1074 | 163 | 23 | GO:0043687 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRAF3IP2 USP34 SLF1 RNF213 ZSWIM2 MIB2 BIRC7 KBTBD2 FBXL21P RNF157 CCNF FEM1B TRIM33 RNF5 UBR5 TRIM56 N4BP1 KLHL12 FBXL2 USP3 KLHL18 MGRN1 | 1.54e-05 | 1009 | 163 | 22 | GO:0070647 |
| GeneOntologyBiologicalProcess | protein ubiquitination | TRAF3IP2 RNF213 ZSWIM2 MIB2 BIRC7 KBTBD2 FBXL21P RNF157 CCNF FEM1B TRIM33 RNF5 UBR5 TRIM56 N4BP1 KLHL12 FBXL2 KLHL18 MGRN1 | 2.33e-05 | 811 | 163 | 19 | GO:0016567 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-3-phosphate biosynthetic process | 2.46e-05 | 22 | 163 | 4 | GO:0036092 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | TRAF3IP2 SLF1 RNF213 ZSWIM2 MIB2 BIRC7 KBTBD2 FBXL21P RNF157 CCNF FEM1B TRIM33 RNF5 UBR5 TRIM56 N4BP1 KLHL12 FBXL2 KLHL18 MGRN1 | 2.66e-05 | 893 | 163 | 20 | GO:0032446 |
| GeneOntologyBiologicalProcess | vacuole organization | ATG16L1 ATG2B ATP10B ARSB RNF5 IFT88 PIK3C2B PIK3C3 ELAPOR1 BECN1 | 3.01e-05 | 249 | 163 | 10 | GO:0007033 |
| GeneOntologyBiologicalProcess | autophagosome assembly | 5.02e-05 | 121 | 163 | 7 | GO:0000045 | |
| GeneOntologyBiologicalProcess | polyol catabolic process | 1.01e-04 | 12 | 163 | 3 | GO:0046174 | |
| GeneOntologyBiologicalProcess | protein targeting to lysosome | 1.29e-04 | 33 | 163 | 4 | GO:0006622 | |
| GeneOntologyBiologicalProcess | organelle assembly | TEKT3 ATG16L1 ATG2B RNF213 FASTKD2 MEF2A MEF2C DNALI1 DNAJB13 GK2 RNF5 KASH5 NDC80 IFT88 PIK3C3 DNAAF10 SYNE2 SEC23IP ELAPOR1 AP1S2 BECN1 | 2.57e-04 | 1138 | 163 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 3.61e-04 | 219 | 163 | 8 | GO:0071248 | |
| GeneOntologyBiologicalProcess | inositol phosphate catabolic process | 3.69e-04 | 4 | 163 | 2 | GO:0071545 | |
| GeneOntologyCellularComponent | axoneme | TEKT3 ATG16L1 DNALI1 DNAJB13 KIFAP3 IFT88 PIK3C3 DNAH6 DNAH11 | 3.69e-05 | 207 | 163 | 9 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | TEKT3 ATG16L1 DNALI1 DNAJB13 KIFAP3 IFT88 PIK3C3 DNAH6 DNAH11 | 3.84e-05 | 208 | 163 | 9 | GO:0097014 |
| GeneOntologyCellularComponent | phagophore assembly site | 2.37e-04 | 39 | 163 | 4 | GO:0000407 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III, type II | 3.59e-04 | 4 | 163 | 2 | GO:0034272 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III, type I | 3.59e-04 | 4 | 163 | 2 | GO:0034271 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 4.58e-04 | 230 | 163 | 8 | GO:0019898 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 5.74e-04 | 238 | 163 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | TEKT3 ATG16L1 DNALI1 DNAJB13 KIFAP3 IFT88 PIK3C3 DNAH6 DNAH11 | 8.81e-04 | 317 | 163 | 9 | GO:0032838 |
| GeneOntologyCellularComponent | supramolecular fiber | TEKT3 KIF26A MEF2C RYR1 RYR3 KIFAP3 FBN1 EML5 SYNJ2 SYNE2 PAK1 NAV3 JAKMIP1 MYO18B FERMT2 DNAH6 UPP2 KRT38 KRT37 DNAH11 | 8.83e-04 | 1179 | 163 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 9.55e-04 | 56 | 163 | 4 | GO:0031234 | |
| GeneOntologyCellularComponent | supramolecular polymer | TEKT3 KIF26A MEF2C RYR1 RYR3 KIFAP3 FBN1 EML5 SYNJ2 SYNE2 PAK1 NAV3 JAKMIP1 MYO18B FERMT2 DNAH6 UPP2 KRT38 KRT37 DNAH11 | 9.59e-04 | 1187 | 163 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class III | 1.24e-03 | 7 | 163 | 2 | GO:0035032 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex | 1.47e-03 | 29 | 163 | 3 | GO:0005942 | |
| GeneOntologyCellularComponent | outer acrosomal membrane | 1.64e-03 | 8 | 163 | 2 | GO:0002081 | |
| GeneOntologyCellularComponent | I band | 1.95e-03 | 166 | 163 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | junctional membrane complex | 2.10e-03 | 9 | 163 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | cytoplasmic region | TEKT3 ATG16L1 DNALI1 DNAJB13 KIFAP3 IFT88 PIK3C3 DNAH6 DNAH11 | 2.12e-03 | 360 | 163 | 9 | GO:0099568 |
| GeneOntologyCellularComponent | SCF ubiquitin ligase complex | 2.19e-03 | 70 | 163 | 4 | GO:0019005 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 2.23e-03 | 230 | 163 | 7 | GO:0098562 | |
| MousePheno | abnormal heart atrium morphology | ATG16L1 TMEM94 MEF2C RBM20 RYR1 FBN1 IFT88 ATP11A MYO18B DNAH11 MGRN1 | 9.19e-06 | 232 | 128 | 11 | MP:0003105 |
| Domain | ARM-type_fold | USP34 NOC2L CIP2A TTI2 ARFGEF1 RYR3 ARFGEF3 KIFAP3 PIK3C2B PIK3C3 IFRD2 HEATR5B TNPO3 XPOT | 1.47e-06 | 339 | 161 | 14 | IPR016024 |
| Domain | NUDIX_hydrolase_CS | 2.50e-06 | 12 | 161 | 4 | IPR020084 | |
| Domain | MADS_MEF2-like | 2.50e-06 | 4 | 161 | 3 | IPR033896 | |
| Domain | MADS_BOX_1 | 1.23e-05 | 6 | 161 | 3 | PS00350 | |
| Domain | MADS | 1.23e-05 | 6 | 161 | 3 | SM00432 | |
| Domain | SRF-TF | 1.23e-05 | 6 | 161 | 3 | PF00319 | |
| Domain | MADS_BOX_2 | 1.23e-05 | 6 | 161 | 3 | PS50066 | |
| Domain | P-loop_NTPase | EP400 TDRD9 KIF26A RNF213 MCM6 LRRK1 NLRP2 NLRC4 MFN1 ORC5 MSH6 NLRP9 GTPBP2 SAMD9L MYO15B RECQL5 NAV3 MYO18B DNAH6 RHOT1 DNAH11 | 1.32e-05 | 848 | 161 | 21 | IPR027417 |
| Domain | TF_MADSbox | 2.15e-05 | 7 | 161 | 3 | IPR002100 | |
| Domain | NUDIX_BOX | 4.94e-05 | 24 | 161 | 4 | PS00893 | |
| Domain | NUDIX | 4.94e-05 | 24 | 161 | 4 | PF00293 | |
| Domain | WD40_repeat_dom | ATG16L1 LRRK1 WDR76 WDR3 SCAP EML5 DNAAF10 WDR20 GNB4 ELP2 DMWD | 5.51e-05 | 297 | 161 | 11 | IPR017986 |
| Domain | NUDIX | 6.86e-05 | 26 | 161 | 4 | PS51462 | |
| Domain | - | EP400 TDRD9 RNF213 MCM6 LRRK1 NLRP2 NLRC4 MFN1 ORC5 MSH6 NLRP9 GTPBP2 SAMD9L RECQL5 NAV3 DNAH6 RHOT1 DNAH11 | 7.97e-05 | 746 | 161 | 18 | 3.40.50.300 |
| Domain | WD40 | 8.57e-05 | 259 | 161 | 10 | PF00400 | |
| Domain | - | 9.27e-05 | 28 | 161 | 4 | 3.90.79.10 | |
| Domain | NUDIX_hydrolase_dom-like | 9.27e-05 | 28 | 161 | 4 | IPR015797 | |
| Domain | NUDIX_hydrolase_dom | 1.07e-04 | 29 | 161 | 4 | IPR000086 | |
| Domain | LRR_6 | 1.10e-04 | 55 | 161 | 5 | PF13516 | |
| Domain | WD40 | 1.14e-04 | 268 | 161 | 10 | SM00320 | |
| Domain | WD40_repeat | 1.28e-04 | 272 | 161 | 10 | IPR001680 | |
| Domain | - | ATG16L1 WDR76 WDR3 SCAP EML5 DNAAF10 WDR20 NUP133 GNB4 ELP2 DMWD | 1.52e-04 | 333 | 161 | 11 | 2.130.10.10 |
| Domain | WD_REPEATS_1 | 1.53e-04 | 278 | 161 | 10 | PS00678 | |
| Domain | WD_REPEATS_2 | 1.58e-04 | 279 | 161 | 10 | PS50082 | |
| Domain | WD_REPEATS_REGION | 1.58e-04 | 279 | 161 | 10 | PS50294 | |
| Domain | WD40/YVTN_repeat-like_dom | ATG16L1 WDR76 WDR3 SCAP EML5 DNAAF10 WDR20 NUP133 GNB4 ELP2 DMWD | 1.60e-04 | 335 | 161 | 11 | IPR015943 |
| Domain | Ryanodine_rcpt | 2.20e-04 | 3 | 161 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 2.20e-04 | 3 | 161 | 2 | IPR009460 | |
| Domain | RyR | 2.20e-04 | 3 | 161 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 2.20e-04 | 3 | 161 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.20e-04 | 3 | 161 | 2 | IPR013333 | |
| Domain | SEC7 | 3.24e-04 | 16 | 161 | 3 | PS50190 | |
| Domain | Sec7 | 3.24e-04 | 16 | 161 | 3 | SM00222 | |
| Domain | Sec7_dom | 3.24e-04 | 16 | 161 | 3 | IPR000904 | |
| Domain | HJURP_C | 4.38e-04 | 4 | 161 | 2 | IPR022102 | |
| Domain | DCB_dom | 4.38e-04 | 4 | 161 | 2 | IPR032629 | |
| Domain | DUF4195 | 4.38e-04 | 4 | 161 | 2 | IPR025243 | |
| Domain | Sec7_C | 4.38e-04 | 4 | 161 | 2 | IPR015403 | |
| Domain | DUF1981 | 4.38e-04 | 4 | 161 | 2 | PF09324 | |
| Domain | HJURP_C | 4.38e-04 | 4 | 161 | 2 | PF12347 | |
| Domain | DUF4195 | 4.38e-04 | 4 | 161 | 2 | PF13836 | |
| Domain | DCB | 4.38e-04 | 4 | 161 | 2 | PF16213 | |
| Domain | BTB | 4.81e-04 | 160 | 161 | 7 | PS50097 | |
| Domain | BTB-kelch_protein | 5.05e-04 | 43 | 161 | 4 | IPR017096 | |
| Domain | BTB | 9.63e-04 | 131 | 161 | 6 | PF00651 | |
| Domain | NACHT | 9.81e-04 | 23 | 161 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 9.81e-04 | 23 | 161 | 3 | IPR007111 | |
| Domain | FBOX | 1.04e-03 | 52 | 161 | 4 | SM00256 | |
| Domain | RIH_assoc-dom | 1.08e-03 | 6 | 161 | 2 | IPR013662 | |
| Domain | Xpo1 | 1.08e-03 | 6 | 161 | 2 | PF08389 | |
| Domain | Ins145_P3_rec | 1.08e-03 | 6 | 161 | 2 | PF08709 | |
| Domain | RIH_assoc | 1.08e-03 | 6 | 161 | 2 | PF08454 | |
| Domain | RIH_dom | 1.08e-03 | 6 | 161 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.08e-03 | 6 | 161 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.08e-03 | 6 | 161 | 2 | IPR015925 | |
| Domain | - | 1.08e-03 | 6 | 161 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.08e-03 | 6 | 161 | 2 | PF01365 | |
| Domain | Exportin-1/Importin-b-like | 1.08e-03 | 6 | 161 | 2 | IPR013598 | |
| Domain | ZF_RING_2 | 1.14e-03 | 298 | 161 | 9 | PS50089 | |
| Domain | SKP1/BTB/POZ | 1.28e-03 | 189 | 161 | 7 | IPR011333 | |
| Domain | RING | 1.34e-03 | 305 | 161 | 9 | SM00184 | |
| Domain | SWIM | 1.51e-03 | 7 | 161 | 2 | PF04434 | |
| Domain | Kelch | 1.57e-03 | 58 | 161 | 4 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 1.67e-03 | 59 | 161 | 4 | IPR011043 | |
| Domain | BACK | 1.78e-03 | 60 | 161 | 4 | SM00875 | |
| Domain | - | ZFYVE27 RNF213 ZSWIM2 MIB2 BIRC7 RNF157 TRIM33 RNF5 TRIM56 USP3 MGRN1 | 1.81e-03 | 449 | 161 | 11 | 3.30.40.10 |
| Domain | BACK | 1.89e-03 | 61 | 161 | 4 | IPR011705 | |
| Domain | BACK | 1.89e-03 | 61 | 161 | 4 | PF07707 | |
| Domain | Znf_U1 | 1.95e-03 | 29 | 161 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 1.95e-03 | 29 | 161 | 3 | SM00451 | |
| Domain | PI3K_C2 | 2.00e-03 | 8 | 161 | 2 | SM00142 | |
| Domain | PI3K_C2_dom | 2.00e-03 | 8 | 161 | 2 | IPR002420 | |
| Domain | PI3K_C2 | 2.00e-03 | 8 | 161 | 2 | PF00792 | |
| Domain | PI3K_C2 | 2.00e-03 | 8 | 161 | 2 | PS51547 | |
| Domain | Znf_RING | 2.12e-03 | 326 | 161 | 9 | IPR001841 | |
| Domain | Znf_RING/FYVE/PHD | ZFYVE27 RNF213 ZSWIM2 MIB2 BIRC7 RNF157 TRIM33 RNF5 TRIM56 USP3 MGRN1 | 2.15e-03 | 459 | 161 | 11 | IPR013083 |
| Domain | ARM-like | 2.41e-03 | 270 | 161 | 8 | IPR011989 | |
| Domain | PI3Ka | 2.55e-03 | 9 | 161 | 2 | PF00613 | |
| Domain | PI3Ka | 2.55e-03 | 9 | 161 | 2 | SM00145 | |
| Domain | ZF_SWIM | 2.55e-03 | 9 | 161 | 2 | PS50966 | |
| Domain | Znf_SWIM | 2.55e-03 | 9 | 161 | 2 | IPR007527 | |
| Domain | - | 2.55e-03 | 9 | 161 | 2 | 1.25.40.70 | |
| Domain | F-box | 2.67e-03 | 67 | 161 | 4 | PF00646 | |
| Domain | Kelch_1 | 3.14e-03 | 70 | 161 | 4 | PF01344 | |
| Domain | Kelch_1 | 3.14e-03 | 70 | 161 | 4 | IPR006652 | |
| Domain | - | 3.18e-03 | 222 | 161 | 7 | 1.25.10.10 | |
| Domain | MIR | 3.18e-03 | 10 | 161 | 2 | PF02815 | |
| Domain | MIR_motif | 3.18e-03 | 10 | 161 | 2 | IPR016093 | |
| Domain | PI_Kinase | 3.18e-03 | 10 | 161 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 3.18e-03 | 10 | 161 | 2 | IPR001263 | |
| Domain | MIR | 3.18e-03 | 10 | 161 | 2 | PS50919 | |
| Domain | MIR | 3.18e-03 | 10 | 161 | 2 | SM00472 | |
| Domain | PIK_HELICAL | 3.18e-03 | 10 | 161 | 2 | PS51545 | |
| Domain | zf-C3HC4 | 3.25e-03 | 223 | 161 | 7 | PF00097 | |
| Domain | FBOX | 3.47e-03 | 72 | 161 | 4 | PS50181 | |
| Domain | ZF_RING_1 | 3.80e-03 | 291 | 161 | 8 | PS00518 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.94e-03 | 37 | 161 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.94e-03 | 37 | 161 | 3 | PF00122 | |
| Domain | F-box_dom | 4.02e-03 | 75 | 161 | 4 | IPR001810 | |
| Domain | Quinoprot_gluc/sorb_DH | 4.61e-03 | 12 | 161 | 2 | IPR011041 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 9.42e-07 | 10 | 118 | 4 | MM14709 | |
| Pathway | REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL | 9.42e-07 | 10 | 118 | 4 | M27051 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 2.79e-06 | 48 | 118 | 6 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.85e-05 | 48 | 118 | 5 | MM14589 | |
| Pubmed | 4.88e-10 | 4 | 165 | 4 | 12370170 | ||
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 12121577 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NOC2L CIP2A TTI2 ARFGEF1 LMBR1 MCM6 SAMHD1 ARFGEF3 SCAP NDC1 RNF5 UBR5 SEC23IP NUP133 TVP23C HEATR5B VPS53 TNPO3 XPOT | 1.29e-07 | 942 | 165 | 19 | 31073040 |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 22764880 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 8575763 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 10207130 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 21531906 | ||
| Pubmed | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. | 4.18e-07 | 4 | 165 | 3 | 7643214 | |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 25416778 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ATG16L1 NOC2L CIP2A AAK1 SNX16 MEF2A TRIM33 UBR5 PIK3C2B DNAAF10 WDR20 SEC23IP AP1S2 GNB4 HEATR5B DMWD FERMT2 BECN1 MTMR9 | 5.60e-07 | 1038 | 165 | 19 | 26673895 |
| Pubmed | TRIO CIP2A RNF213 RBM20 MSH6 NDC1 SSU72 DNAAF10 WDR20 SYNE2 PLCL2 NUP133 PHLPP1 GNB4 ELP2 DMWD MTMR9 XPOT FTSJ3 | 6.56e-07 | 1049 | 165 | 19 | 27880917 | |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 15084602 | ||
| Pubmed | The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. | 1.04e-06 | 5 | 165 | 3 | 7646512 | |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 8993831 | ||
| Pubmed | Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. | 1.04e-06 | 5 | 165 | 3 | 19093215 | |
| Pubmed | Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. | 1.04e-06 | 5 | 165 | 3 | 12694204 | |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 10458488 | ||
| Pubmed | Regulatory role of MEF2D in serum induction of the c-jun promoter. | 1.04e-06 | 5 | 165 | 3 | 7760790 | |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 16504037 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TRAF3IP2 ATG16L1 CIP2A ATG2B AAK1 MCM6 XRCC4 DNALI1 KIFAP3 CYFIP1 EML5 IFT88 DNAAF10 TRIM56 WDR20 SEC23IP PLCL2 NUP133 FERMT2 VPS53 TNPO3 | 1.33e-06 | 1321 | 165 | 21 | 27173435 |
| Pubmed | The expression of MEF2 genes is implicated in CNS neuronal differentiation. | 2.08e-06 | 6 | 165 | 3 | 9013788 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 12861002 | ||
| Pubmed | USP34 ZFYVE27 EP400 ARFGEF1 RNF213 KBTBD2 ARFGEF3 WDR3 TRIM33 GTPBP2 NDC1 UBR5 WDR20 SEC23IP FERMT2 | 4.94e-06 | 777 | 165 | 15 | 35844135 | |
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 5.77e-06 | 8 | 165 | 3 | 30205047 | |
| Pubmed | ISYNA1 CIP2A ATG2B COQ8B MCM6 FASTKD2 ORC5 MSH6 SEC23IP NUP133 VPS53 XPOT MGRN1 | 7.13e-06 | 606 | 165 | 13 | 36538041 | |
| Pubmed | 7.88e-06 | 210 | 165 | 8 | 16565220 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 25825496 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.08e-05 | 104 | 165 | 6 | 31240132 | |
| Pubmed | 1.08e-05 | 104 | 165 | 6 | 10470851 | ||
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 30276662 | ||
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 24705551 | ||
| Pubmed | MCM6 WDR3 TRIM33 ORC5 MSH6 CYFIP1 NDC1 SEC23IP NUP133 ELP2 TNPO3 XPOT | 1.64e-05 | 560 | 165 | 12 | 35241646 | |
| Pubmed | Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. | 1.68e-05 | 11 | 165 | 3 | 9162005 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 EP400 TRIO KIF26A TMEM94 MIB2 LRRK1 ZBTB42 ELAC2 RYR1 SCAP SLC45A3 PIK3C2B SSU72 IFRD2 DMWD TNPO3 | 2.20e-05 | 1105 | 165 | 17 | 35748872 |
| Pubmed | A comprehensive framework of E2-RING E3 interactions of the human ubiquitin-proteasome system. | 2.21e-05 | 118 | 165 | 6 | 19690564 | |
| Pubmed | Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. | 2.24e-05 | 2 | 165 | 2 | 16469744 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25336633 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9430690 | ||
| Pubmed | GA binding protein augments autophagy via transcriptional activation of BECN1-PIK3C3 complex genes. | 2.24e-05 | 2 | 165 | 2 | 25046113 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9489997 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 2.24e-05 | 2 | 165 | 2 | 12640042 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12689335 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 14592949 | ||
| Pubmed | Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins. | 2.24e-05 | 2 | 165 | 2 | 21741404 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16874027 | ||
| Pubmed | Identification of a candidate therapeutic autophagy-inducing peptide. | 2.24e-05 | 2 | 165 | 2 | 23364696 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9799464 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 17611778 | ||
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 2.24e-05 | 2 | 165 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 2.24e-05 | 2 | 165 | 2 | 11500519 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12105228 | ||
| Pubmed | Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. | 2.24e-05 | 2 | 165 | 2 | 25714112 | |
| Pubmed | Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. | 2.24e-05 | 2 | 165 | 2 | 23658055 | |
| Pubmed | Miro1 functions as an inhibitory regulator of MFN at elevated mitochondrial Ca2+ levels. | 2.24e-05 | 2 | 165 | 2 | 34431132 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12565913 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9192302 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7556644 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 2.24e-05 | 2 | 165 | 2 | 15894801 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16390869 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9817784 | ||
| Pubmed | USP34 EP400 COQ8B RNF213 JAK1 TRIM33 MSH6 GTPBP2 ARSB EML5 UBR5 TRIM56 WDR20 ELF3 VPS53 RHOT1 FTSJ3 | 2.49e-05 | 1116 | 165 | 17 | 31753913 | |
| Pubmed | 2.85e-05 | 251 | 165 | 8 | 29778605 | ||
| Pubmed | 2.87e-05 | 183 | 165 | 7 | 23956138 | ||
| Pubmed | 3.67e-05 | 14 | 165 | 3 | 12130539 | ||
| Pubmed | 3.67e-05 | 14 | 165 | 3 | 31346084 | ||
| Pubmed | LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance. | 4.58e-05 | 15 | 165 | 3 | 30245008 | |
| Pubmed | 4.58e-05 | 15 | 165 | 3 | 16417406 | ||
| Pubmed | USP34 EP400 KIF26A AAK1 FASTKD2 LRRK1 KBTBD2 SLC7A6 TRIM33 SYNJ2 MGRN1 | 4.88e-05 | 529 | 165 | 11 | 14621295 | |
| Pubmed | Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. | 5.33e-05 | 138 | 165 | 6 | 28786561 | |
| Pubmed | 5.46e-05 | 85 | 165 | 5 | 19028597 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | CPNE8 TRIO MAP4K3 NOC2L CIP2A AAK1 KBTBD2 WDR3 NDC80 UBR5 SYNJ2 FERMT2 MTMR9 FTSJ3 | 6.08e-05 | 853 | 165 | 14 | 28718761 |
| Pubmed | 6.11e-05 | 87 | 165 | 5 | 37495603 | ||
| Pubmed | 6.63e-05 | 283 | 165 | 8 | 21903422 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 18403125 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 11171121 | ||
| Pubmed | GADD45A inhibits autophagy by regulating the interaction between BECN1 and PIK3C3. | 6.69e-05 | 3 | 165 | 2 | 26636486 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 32054686 | ||
| Pubmed | VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy. | 6.69e-05 | 3 | 165 | 2 | 23315026 | |
| Pubmed | Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. | 6.69e-05 | 3 | 165 | 2 | 16179260 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 11792813 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 7876312 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 6.69e-05 | 3 | 165 | 2 | 18093911 | |
| Pubmed | Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. | 6.69e-05 | 3 | 165 | 2 | 22258505 | |
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 6.69e-05 | 3 | 165 | 2 | 22496871 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 22948152 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 15728583 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 38866787 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 6.69e-05 | 3 | 165 | 2 | 10788707 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 17203969 | ||
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 6.69e-05 | 3 | 165 | 2 | 7621815 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 31680123 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 16102578 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 27989458 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 17491012 | ||
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 6.69e-05 | 3 | 165 | 2 | 10473538 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 18313230 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 1516833 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 18434746 | ||
| Pubmed | HLA-C expression in extravillous trophoblasts is determined by an ELF3-NLRP2/NLRP7 regulatory axis. | 6.69e-05 | 3 | 165 | 2 | 39052836 | |
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 6.69e-05 | 3 | 165 | 2 | 9204703 | |
| Interaction | GPR17 interactions | ZFYVE27 CIP2A TTI2 COQ8B ARFGEF1 LMBR1 RNF213 MFN1 ARFGEF3 TVP23C HEATR5B VPS53 TNPO3 XPOT | 6.71e-08 | 283 | 161 | 14 | int:GPR17 |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.16e-06 | 4 | 121 | 3 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 2.90e-06 | 5 | 121 | 3 | 1086 | |
| GeneFamily | WD repeat domain containing | 1.06e-05 | 262 | 121 | 10 | 362 | |
| GeneFamily | Nudix hydrolase family | 1.83e-05 | 24 | 121 | 4 | 667 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.33e-04 | 3 | 121 | 2 | 287 | |
| GeneFamily | Dyneins, axonemal | 1.86e-04 | 17 | 121 | 3 | 536 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 2.84e-04 | 134 | 121 | 6 | 861 | |
| GeneFamily | F-box and leucine rich repeat proteins | 3.56e-04 | 21 | 121 | 3 | 558 | |
| GeneFamily | NLR family | 6.04e-04 | 25 | 121 | 3 | 666 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 1.21e-03 | 8 | 121 | 2 | 831 | |
| GeneFamily | Autophagy related | 1.38e-03 | 33 | 121 | 3 | 1022 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 1.55e-03 | 9 | 121 | 2 | 90 | |
| GeneFamily | Ring finger proteins | 2.53e-03 | 275 | 121 | 7 | 58 | |
| GeneFamily | Kelch like|BTB domain containing | 2.78e-03 | 42 | 121 | 3 | 617 | |
| GeneFamily | ATPase phospholipid transporting | 4.41e-03 | 15 | 121 | 2 | 1210 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 4.56e-03 | 50 | 121 | 3 | 1293 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.34e-03 | 18 | 121 | 2 | 91 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 TRIO ARFGEF1 XRCC4 MEF2A KIFAP3 TRIM33 ORC5 MSH6 NDC80 UBR5 SYNJ2 PIK3C3 SYNE2 NUP133 NAV3 PHLPP1 N4BP1 FERMT2 ZNF292 | 4.45e-07 | 856 | 164 | 20 | M4500 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CPNE8 SLF1 NOC2L CIP2A MCM6 SAMHD1 WDR76 MEF2C CCNF JAK1 MSH6 NDC1 NDC80 IFRD2 NUP133 | 3.82e-06 | 578 | 164 | 15 | M2368 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CPNE8 SLF1 NOC2L CIP2A MCM6 SAMHD1 WDR76 MEF2C CCNF JAK1 MSH6 NDC1 NDC80 IFRD2 NUP133 | 5.63e-06 | 597 | 164 | 15 | MM1309 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP | KLHL6 USP34 CPNE8 TRIO AAK1 SAMHD1 MEF2C SAMD9L CYFIP1 RNF5 PIK3C3 SEC23IP AP1S2 ALDH1A1 | 1.29e-05 | 562 | 164 | 14 | M41008 |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-07 | 179 | 164 | 8 | de3245e1ee269e422de0308d0dd3623e4e9eb182 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-07 | 179 | 164 | 8 | c41c11171dfb40e5ddea6bf97d9373eb03a2321b | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.08e-07 | 183 | 164 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.65e-07 | 191 | 164 | 8 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.11e-06 | 159 | 164 | 7 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | facs-Lung-Endomucin-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-06 | 176 | 164 | 7 | 9b58734017ceabe81f490dd0b9f3192bc903d455 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 4.78e-06 | 180 | 164 | 7 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 4.78e-06 | 180 | 164 | 7 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 185 | 164 | 7 | 60206c7322b4ddb2010040aac70561df842c9843 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 6.82e-06 | 190 | 164 | 7 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.06e-06 | 191 | 164 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.06e-06 | 191 | 164 | 7 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.08e-06 | 195 | 164 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 8.63e-06 | 197 | 164 | 7 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 8.92e-06 | 198 | 164 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 8.92e-06 | 198 | 164 | 7 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 8.92e-06 | 198 | 164 | 7 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.22e-06 | 199 | 164 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.53e-06 | 200 | 164 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.53e-06 | 200 | 164 | 7 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-05 | 150 | 164 | 6 | c922dbb4c9c12ccf08bd5f6168b20606c605d052 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 152 | 164 | 6 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 156 | 164 | 6 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.06e-05 | 162 | 164 | 6 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-05 | 164 | 164 | 6 | c4ad98106e8663caf7c1c15d30ec633d8bd8cf57 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-05 | 164 | 164 | 6 | ed7277f8980f96f5b3e4eed025d46d0942e123d7 | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 3.51e-05 | 166 | 164 | 6 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 167 | 164 | 6 | 3c4183a8225bae37b9f5341ebd1b95409ced2022 | |
| ToppCell | facs-Kidney-nan-24m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 167 | 164 | 6 | 28e9670586ff551b700c794313d27eedbfa1286b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 170 | 164 | 6 | 059f7ae615342ea19f43b0a405cd7272251a78a9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.14e-05 | 171 | 164 | 6 | b51bbeacb172e8b5de519ada85543d7ae9914b3c | |
| ToppCell | droplet-Fat-Mat-18m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 172 | 164 | 6 | 226de1a5d4a360d3ae01b0235fea19521ec623a0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 175 | 164 | 6 | 98dc3b6f69a29d587f503898f09912700950e3d9 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 175 | 164 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 176 | 164 | 6 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.34e-05 | 179 | 164 | 6 | af35ef8a7768cee0c2af0590e5bec35cee6a4714 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 5.34e-05 | 179 | 164 | 6 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.68e-05 | 181 | 164 | 6 | a6c8b33a392de3df2f179317e329e45d3d8c6f52 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.68e-05 | 181 | 164 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-05 | 185 | 164 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 186 | 164 | 6 | 6568358812f0ca4e0161a1a1b29682fbced35c79 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-05 | 187 | 164 | 6 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.01e-05 | 188 | 164 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 7.01e-05 | 188 | 164 | 6 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.01e-05 | 188 | 164 | 6 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-05 | 188 | 164 | 6 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.22e-05 | 189 | 164 | 6 | 2157a2d40613f7d5ce2e7dbd266df441e449cdaf | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.43e-05 | 190 | 164 | 6 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 190 | 164 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-05 | 190 | 164 | 6 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | COPD-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 7.43e-05 | 190 | 164 | 6 | 1e85ee686ff6dd27c69415d524d54fa825b1daad | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-05 | 190 | 164 | 6 | 2fdc024d3d673a0134b74b4c5a63afe924995730 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 118 | 164 | 5 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 118 | 164 | 5 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.65e-05 | 191 | 164 | 6 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.10e-05 | 193 | 164 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | IIH-CD8|IIH / Condition, Cell_class and T cell subcluster | 8.10e-05 | 193 | 164 | 6 | 343ac8c6dc6d7c7a944a14de65f1d4ea3dfafe86 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.10e-05 | 193 | 164 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | IIH-CD8-CD8_1|IIH / Condition, Cell_class and T cell subcluster | 8.10e-05 | 193 | 164 | 6 | c5a4926003906d6726155f19061b73fb45d9962c | |
| ToppCell | HSPCs-Ery_prog.|World / Lineage and Cell class | 8.10e-05 | 193 | 164 | 6 | 484c2e0daedc6cb0d50d164add8c1658123a60f9 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 8.33e-05 | 194 | 164 | 6 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.57e-05 | 195 | 164 | 6 | 7bb3bdfb8caaae357b1f7841d8d00936c4373dfe | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.57e-05 | 195 | 164 | 6 | 19413dc6aa0010686cdfa0c750ef0a7a76caf308 | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 8.57e-05 | 195 | 164 | 6 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 8.57e-05 | 195 | 164 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 195 | 164 | 6 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | PBMC-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 8.57e-05 | 195 | 164 | 6 | 674355ca00314bde90ef7f6ddb83afe2d5323130 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|World / disease group, cell group and cell class | 8.57e-05 | 195 | 164 | 6 | 070c5d3bdbd4ea54a579c01c37fb99bcf823982e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.57e-05 | 195 | 164 | 6 | d579150d176e6bd81004b5146de4901ca13a3c3e | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 195 | 164 | 6 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.06e-05 | 197 | 164 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.06e-05 | 197 | 164 | 6 | 2e9677b4b9a7c88db16416e5f114a2031ec3bc24 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.06e-05 | 197 | 164 | 6 | 4c9919914079e76b1d2220b249e0d0b0d9bf4bc0 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.06e-05 | 197 | 164 | 6 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | COVID-19_Moderate-CD8+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 9.06e-05 | 197 | 164 | 6 | 4711ecb157e907758a5021248ae8b043d17672c6 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.06e-05 | 197 | 164 | 6 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.06e-05 | 197 | 164 | 6 | 9838dbd1623babf8de7e9126a28fe5d3666bce42 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 9.06e-05 | 197 | 164 | 6 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.32e-05 | 198 | 164 | 6 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.32e-05 | 198 | 164 | 6 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.32e-05 | 198 | 164 | 6 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.32e-05 | 198 | 164 | 6 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.58e-05 | 199 | 164 | 6 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK_activated|COVID-19_Severe / Disease group, lineage and cell class | 9.58e-05 | 199 | 164 | 6 | edf5f80b4c299e6bf462675f2cd3329d86c923d8 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 9.58e-05 | 199 | 164 | 6 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.58e-05 | 199 | 164 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.58e-05 | 199 | 164 | 6 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.85e-05 | 200 | 164 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.85e-05 | 200 | 164 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.85e-05 | 200 | 164 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 9.85e-05 | 200 | 164 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.85e-05 | 200 | 164 | 6 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 9.85e-05 | 200 | 164 | 6 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 9.85e-05 | 200 | 164 | 6 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| Disease | unipolar depression, bipolar disorder, mental or behavioural disorder | 3.09e-06 | 6 | 160 | 3 | EFO_0000677, EFO_0003761, MONDO_0004985 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.42e-06 | 75 | 160 | 6 | DOID:1059 (implicated_via_orthology) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 6.59e-06 | 128 | 160 | 7 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 6.59e-06 | 128 | 160 | 7 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 6.59e-06 | 128 | 160 | 7 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 6.59e-06 | 128 | 160 | 7 | C1306837 | |
| Disease | Renal Cell Carcinoma | 6.59e-06 | 128 | 160 | 7 | C0007134 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.70e-05 | 148 | 160 | 7 | C0279702 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-05 | 152 | 160 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | chronic lymphocytic leukemia | 4.85e-05 | 119 | 160 | 6 | EFO_0000095 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 8.73e-05 | 3 | 160 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 8.73e-05 | 3 | 160 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.01e-04 | 17 | 160 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Paroxysmal atrial fibrillation | 2.15e-04 | 156 | 160 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 2.15e-04 | 156 | 160 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.15e-04 | 156 | 160 | 6 | C2585653 | |
| Disease | Atrial Fibrillation | 2.47e-04 | 160 | 160 | 6 | C0004238 | |
| Disease | response to bevacizumab, Proteinuria | 2.89e-04 | 5 | 160 | 2 | EFO_0005943, HP_0000093 | |
| Disease | obsolete_red blood cell distribution width | ZNF280D EP400 ZNF407 MCM6 SAMHD1 KBTBD2 PRSS36 CCNF OR2M4 TRIM33 CYFIP1 NUDT4 TRIM56 WDR20 SYNE2 PLCL2 ATP11A FBXL20 | 3.91e-04 | 1347 | 160 | 18 | EFO_0005192 |
| Disease | Intellectual Disability | 7.81e-04 | 447 | 160 | 9 | C3714756 | |
| Disease | stachydrine measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0021169 | |
| Disease | atrial fibrillation | 9.86e-04 | 371 | 160 | 8 | EFO_0000275 | |
| Disease | Dystonia | 1.25e-03 | 86 | 160 | 4 | C0013421 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.65e-03 | 43 | 160 | 3 | DOID:9074 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 1.67e-03 | 93 | 160 | 4 | C1535926 | |
| Disease | biliary liver cirrhosis | 1.76e-03 | 44 | 160 | 3 | EFO_0004267 | |
| Disease | pulse pressure measurement, social deprivation | 2.55e-03 | 14 | 160 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | inflammatory biomarker measurement, YKL40 measurement | 2.69e-03 | 51 | 160 | 3 | EFO_0004869, EFO_0004872 | |
| Disease | response to acetylsalicylate | 3.34e-03 | 16 | 160 | 2 | GO_1903492 | |
| Disease | prostate carcinoma | TRIO KCTD19 RNF213 RFX7 ZBTB42 NUDT11 PIK3C2B SYNE2 FERMT2 VPS53 MTMR9 DNAH11 | 3.50e-03 | 891 | 160 | 12 | EFO_0001663 |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 3.77e-03 | 17 | 160 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | 1-Methylhistidine measurement | 3.77e-03 | 17 | 160 | 2 | EFO_0021543 | |
| Disease | Moyamoya Disease | 3.77e-03 | 17 | 160 | 2 | C0026654 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CKICELSFETDQVLL | 366 | P59817 | |
| RGITLVCLNCDFLSD | 686 | Q6N043 | |
| TLCRCGESLQDVIDR | 1816 | Q96L91 | |
| VLQIFCDTCEAVARL | 151 | Q2M2I8 | |
| IAECLQTISDLETEC | 131 | Q676U5 | |
| RCAIRIACIFSIQLE | 981 | Q9Y6D6 | |
| EQCLDVTCFSDVIRF | 1646 | Q7Z2Y8 | |
| TFIIDLCVCLFQRAR | 2026 | Q7Z2Y8 | |
| TDDGCFLELRVCSIQ | 446 | Q9BX10 | |
| CKLEDFQEVSDLRCL | 236 | Q9UNA3 | |
| LVIFQVCLCQDEVTD | 16 | P32248 | |
| LESIFVCSEDIRIQL | 1546 | Q96DT5 | |
| LQEERTCKVCLDRAV | 246 | Q96CA5 | |
| QCCIAASRIFVEESI | 301 | P00352 | |
| TLCNCALEELRLVFG | 101 | P78545 | |
| LTVLLFLEDCIITAC | 606 | Q09019 | |
| CCELDISIVDRLNSL | 681 | Q96BY7 | |
| QETCESILNCALEEL | 946 | O94823 | |
| ACLCFRSEREDEVLL | 21 | Q8NFP7 | |
| LCSEEELQLIRQACV | 36 | O95199 | |
| CLCVTTTLDLDLAQD | 946 | Q5T481 | |
| TAEELCIRAAQACRI | 56 | P23458 | |
| IDREELCETVSSCFL | 91 | Q9Y5H2 | |
| ALLTELCQRVSFCTD | 431 | Q9NPH2 | |
| VALIECECSEFRFIV | 201 | Q17RG1 | |
| FECEHLICQRDTILS | 296 | Q8N6L0 | |
| EICRLSVLVDEFCSE | 416 | Q8IWA4 | |
| FCCAIEDQDNELITL | 66 | P56377 | |
| FCLLIEQSLSLEEVC | 1006 | Q7L576 | |
| REVSQVDTICECLLE | 691 | Q8WUM0 | |
| LRIFSFLDIVTLCRC | 21 | Q9UKC9 | |
| FLCLDCQTVIRDVEQ | 156 | Q14566 | |
| QLERDTILVCLDCCI | 781 | Q8IVH8 | |
| FLEELCRILNCSETV | 61 | Q7Z418 | |
| LTDVILCVDIQEFSC | 71 | Q8WZ60 | |
| DLEEIQLVSCCLSAN | 821 | Q9NPP4 | |
| AACLCFRSEQEDEVL | 21 | A0A024RBG1 | |
| ESLAEVVLQNCRCLD | 496 | P61550 | |
| ILTTACLAAQCIDRE | 311 | Q96QG7 | |
| EDCVLTAIERDFISC | 1191 | Q38SD2 | |
| CQSEILELRCTVNAL | 316 | O76014 | |
| LVACNILCLLVDETA | 311 | Q8WVP7 | |
| NECVVCLSDLRDTLI | 276 | O60291 | |
| CQSEILELRCTVNAL | 316 | O76015 | |
| RITFVFETLCSVNCE | 496 | Q6UXG2 | |
| LCEECTDTLLDQLDT | 136 | Q14457 | |
| DIECVLRCSVLEIEQ | 406 | Q9UK73 | |
| LCVCSSFDQTVRVLI | 336 | Q96MX6 | |
| FLTEAEIICDVVCLV | 481 | Q8IXI2 | |
| ETSAFERLLVICCVV | 191 | Q96R27 | |
| AACLCFRSESEEEVL | 21 | O95989 | |
| AACLCFRSEQEDEVL | 21 | Q9NZJ9 | |
| RSRICECTEAEAEII | 1786 | Q8IVL0 | |
| DLTTESNLLECIRAC | 36 | P01189 | |
| ETACFLQVEDVLQRC | 106 | Q8IY47 | |
| FRCSTFAELQERLEC | 836 | Q9ULI4 | |
| SVLCDCEIALIIFNS | 36 | Q06413 | |
| LSCCRFLDDSQIVTS | 146 | Q9HAV0 | |
| FRVLELEVRDSICCK | 596 | Q96N16 | |
| VRILCEQIASDTCHL | 716 | Q9NX02 | |
| ACLCFRSEREDEVLL | 21 | Q96G61 | |
| SVLCDCEIALIIFNS | 36 | Q02078 | |
| VECIAVLDVLLCLAN | 1051 | P52701 | |
| ITIAIEKEECRFCIS | 26 | P01225 | |
| VCCSRLFEVTDVNKL | 871 | Q9UPP2 | |
| ALVTFCIRDLIGCLQ | 206 | Q9Y3T9 | |
| RELVVNCCTEFIHLI | 36 | Q01658 | |
| SVLCDCEIALIIFNS | 36 | Q02080 | |
| SFEVCLCLLVAISTE | 156 | P35410 | |
| TVLCDRLQEALTFTC | 381 | O00750 | |
| LLCEQILRDTFSESC | 1266 | Q96JP2 | |
| AAAVSILTQRICDCL | 726 | Q5K4E3 | |
| IAAVCRECLQALEFL | 366 | Q13153 | |
| SAIVCCIQIFSLDLV | 191 | P81408 | |
| ACDLVTLVVRACDLA | 886 | Q9BYE9 | |
| CCFDEFNRIDIEVLS | 1521 | Q9C0G6 | |
| ENVECLRFLVRLCTD | 686 | Q13099 | |
| ATRVFAADCLCRIIN | 1246 | Q9P2D3 | |
| FIRCSLQCRDLVDEA | 241 | Q53G59 | |
| FLSDRVQQDDLVRCC | 236 | O94889 | |
| ECIARTCEKLDELNI | 66 | Q14410 | |
| FTSLCLHLTVECVDR | 326 | P41002 | |
| TGRICLDIRLETCFL | 946 | P35555 | |
| SLCDDVVSVLTVLCE | 201 | Q5TH69 | |
| IICFLNLVIECDLET | 26 | Q5K131 | |
| TLRTIANDDCELCVN | 91 | Q16661 | |
| ICFQLLTLCLRELFE | 346 | Q96D53 | |
| CFDELIREVTINCAE | 131 | O14645 | |
| DIQDLVSCLACLESV | 261 | Q12894 | |
| CTLIDALNVTRCALD | 181 | P15848 | |
| ALTCCTVEVRTLDDR | 241 | P59910 | |
| DLQTILCLACARDEL | 196 | Q05BV3 | |
| DLFLASCSQDCLIRI | 221 | Q6IA86 | |
| EVRLSFICTEVDCKV | 631 | Q96AC1 | |
| LRVFRLEDSCCLFTL | 1101 | Q12770 | |
| LRADAVVCLAVCAFI | 36 | Q9H228 | |
| VVCLAVCAFIVLENL | 41 | Q9H228 | |
| LAICCFVLEQSLSVR | 61 | P21817 | |
| IILTAEELNCCRDAV | 146 | Q86YQ8 | |
| CSDERIDLELISFCI | 436 | Q92845 | |
| VASLEACAVRLCELQ | 116 | A6NK58 | |
| DCSQCIDLLNRRIFI | 1736 | Q3ZCN5 | |
| ECLVCSELALLVLFS | 831 | Q96AX9 | |
| EVSCSAFIRFVRLCE | 376 | Q9UKT6 | |
| AAVVCVTLLDRLDCD | 271 | O95045 | |
| QEQLKLFCETCDRLT | 281 | Q9UPN9 | |
| ECVVCLSDVRDTLIL | 276 | Q96PX1 | |
| ECNICLETAREAVVS | 26 | Q99942 | |
| ALVTECLEQCGRVLE | 1521 | Q8WXH0 | |
| CLDCLDRTNTVQSFI | 386 | O15056 | |
| ISERDVLCVQIAGLC | 191 | Q9Y3Z3 | |
| IDFCLTRTLVCDEDT | 461 | Q8NDG6 | |
| DVLTALEILCENECT | 651 | Q8IVG5 | |
| VNCVECFTLRLLLEQ | 61 | O43913 | |
| IFSFLDVVTLCRCAQ | 36 | Q96IG2 | |
| RINECDEICLSVLST | 261 | Q9NYY8 | |
| RFQLCKELSELVSIC | 611 | Q9UPR0 | |
| LEQDLCTFLISRACK | 471 | Q8NEB9 | |
| TTEDIRVCCQDIRVL | 286 | Q8IY81 | |
| EAQLLTEVDTILCCQ | 216 | Q9BXF9 | |
| LTVLIFLEDCIVTAC | 536 | Q8TBZ3 | |
| VCDLRFRSIIECVDD | 456 | Q9Y6Y8 | |
| EECLFGLLTLIFLTC | 196 | Q96JT2 | |
| LTSECLSCLVELLED | 51 | Q8TCG1 | |
| CLRTQVLEDSEDSFC | 91 | O43734 | |
| RELFLEICRSCSAVL | 781 | P98196 | |
| CLESLSQCEADREAI | 526 | Q7RTR0 | |
| CRTREACEQLAIELS | 266 | O94762 | |
| DECSFVSLRDVERCV | 2631 | Q63HN8 | |
| EVLVELIESRLFCRC | 196 | Q8N2E2 | |
| LFFRVSAIIVCLLCE | 41 | Q96ET8 | |
| DDSLSLKVFRCLVCQ | 711 | Q9C0A1 | |
| CLVCQAFSTDSLELL | 721 | Q9C0A1 | |
| SSLLRTCDLEEFQTC | 626 | Q9BQ52 | |
| LNLCDASVTERLCRF | 591 | Q12767 | |
| QEATDCLILLDRCSQ | 456 | Q6NXR4 | |
| AQRDTIEECLLAICN | 2461 | Q15413 | |
| EVIRELICYCLDTIA | 121 | Q13426 | |
| CENVALVLERLALSC | 96 | O60281 | |
| NIDEEVISSACRLVC | 116 | Q2KHR2 | |
| EDCVFIKELLRNCLS | 206 | Q6BDI9 | |
| LEELCLICNILSTAE | 546 | Q5VIR6 | |
| VEVLIRSCLFNESFC | 506 | Q9BQI6 | |
| LTCDLEDTCVLLENQ | 1581 | Q8IUG5 | |
| CRIFTELCETFLEKI | 296 | Q9Y5L0 | |
| IDSEDICSICQELLL | 141 | Q8NEG5 | |
| QQRELGFLCDCTVLV | 16 | B2RXF5 | |
| TQQLCFCVLTELDVA | 491 | Q92536 | |
| VCSLRDCLRSFTDLE | 361 | Q9Y6I4 | |
| SFLIQLEAFLSRLCC | 151 | Q5T4F4 | |
| VVTTCADCNLRIFDS | 511 | Q9H967 | |
| IEVLREEACDCLFEV | 236 | O43592 | |
| FREQQSLLDCILCFV | 406 | Q96MP5 | |
| VLHCERNQLVTLDIC | 856 | O60346 | |
| ADCERLSAQIEECIF | 161 | Q15560 | |
| NIGLSFEECIERVCI | 766 | Q9C0G0 | |
| LLCRVAINCEKFTET | 3151 | Q70CQ2 | |
| ICCISEILDQAEFAD | 1986 | Q9BXT5 | |
| EFIQLGSDVELICRC | 841 | Q9UNX4 | |
| IANCLAVREFLCLDD | 201 | P57768 | |
| CKDLFDLILTCEERV | 101 | Q9NP77 | |
| SVEETCLNICRLDFS | 2996 | O75962 | |
| SDFLACKICLEQLRA | 16 | Q9BRZ2 | |
| QDIFECRTCGLLESL | 1191 | O95071 | |
| CSEVTEIFELSELCV | 96 | Q9NR11 | |
| FRCVTEQCATAIFLL | 146 | P48048 | |
| SLIQDTCADLCILDI | 101 | O75113 | |
| SCVESLFLVRNFCIL | 216 | Q9BTX1 | |
| FIQQCIRQLCEFLTE | 91 | O14777 |